Detalhe da pesquisa
1.
TBX2 acts as a potent transcriptional silencer of tumour suppressor genes through interaction with the CoREST complex to sustain the proliferation of breast cancers.
Nucleic Acids Res
; 50(11): 6154-6173, 2022 06 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-35687133
2.
NUP98 - a novel predictor of response to anthracycline-based chemotherapy in triple negative breast cancer.
BMC Cancer
; 19(1): 236, 2019 Apr 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30935371
3.
Defining the molecular evolution of extrauterine high grade serous carcinoma.
Gynecol Oncol
; 155(2): 305-317, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31493898
4.
Identification and SAR exploration of a novel series of Legumain inhibitors.
Bioorg Med Chem Lett
; 29(12): 1546-1548, 2019 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31005445
5.
Development of a potent and selective cell penetrant Legumain inhibitor.
Bioorg Med Chem Lett
; 25(23): 5642-5, 2015 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26522952
6.
BRCA1 is a key regulator of breast differentiation through activation of Notch signalling with implications for anti-endocrine treatment of breast cancers.
Nucleic Acids Res
; 41(18): 8601-14, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-23863842
7.
The prognostic significance of the aberrant extremes of p53 immunophenotypes in breast cancer.
Histopathology
; 65(3): 340-52, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-24612173
8.
A bespoke target selection tool to guide biomarker discovery in tubo-ovarian cancer.
Comput Struct Biotechnol J
; 20: 3359-3371, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35832628
9.
Osteopontin can act as an effector for a germline mutation of BRCA1 in malignant transformation of breast cancer-related cells.
Cancer Sci
; 101(6): 1354-60, 2010 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-20384635
10.
BRCA1 transcriptionally regulates genes associated with the basal-like phenotype in breast cancer.
Breast Cancer Res Treat
; 122(3): 721-31, 2010 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-19882246
11.
Liquid biopsy in ovarian cancer: Catching the silent killer before it strikes.
World J Clin Oncol
; 11(11): 868-889, 2020 Nov 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-33312883
12.
Pin1 plays a key role in the response to treatment and clinical outcome in triple negative breast cancer.
Ther Adv Med Oncol
; 12: 1758835920906047, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32215056
13.
Glucocorticoid Receptor Expression Predicts Good Outcome in response to Taxane-Free, Anthracycline-Based Therapy in Triple Negative Breast Cancer.
J Oncol
; 2020: 3712825, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32565802
14.
Investigating Radiotherapy Response in a Novel Syngeneic Model of Prostate Cancer.
Cancers (Basel)
; 12(10)2020 Sep 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-33003551
15.
Fibroblast-derived Gremlin1 localises to epithelial cells at the base of the intestinal crypt.
Oncotarget
; 10(45): 4630-4639, 2019 Jul 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-31384391
16.
BRCA1 regulates IFN-gamma signaling through a mechanism involving the type I IFNs.
Mol Cancer Res
; 5(3): 261-70, 2007 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-17374731
17.
BRCA1 mRNA expression levels predict for overall survival in ovarian cancer after chemotherapy.
Clin Cancer Res
; 13(24): 7413-20, 2007 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-18094425
18.
Automated Tumour Recognition and Digital Pathology Scoring Unravels New Role for PD-L1 in Predicting Good Outcome in ER-/HER2+ Breast Cancer.
J Oncol
; 2018: 2937012, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30651729
19.
BRCA1--a good predictive marker of drug sensitivity in breast cancer treatment?
Biochim Biophys Acta
; 1766(2): 205-16, 2006 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-16919882
20.
BRCA1 and c-Myc associate to transcriptionally repress psoriasin, a DNA damage-inducible gene.
Cancer Res
; 65(22): 10265-72, 2005 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-16288014